Gastrointestinal Disorders

Stem cell regenerative therapy holds promise in treating gastrointestinal issues such as Irritable Bowel Syndrome (IBS), Crohn's disease, Celiac disease, and other digestive disorders. Umbilical cord tissue-derived mesenchymal stem cells have unique properties that make them suitable for addressing these conditions.

In IBS, Crohn's, and Celiac disease, there is often inflammation and damage to the gastrointestinal lining, leading to symptoms like abdominal pain, diarrhea, and malabsorption of nutrients. Mesenchymal stem cells possess anti-inflammatory properties and can secrete various growth factors that promote tissue repair and regeneration.

When these stem cells are administered to patients with gastrointestinal disorders, they migrate to the damaged areas and help reduce inflammation. They also stimulate the growth of new healthy cells, restoring the integrity of the gut lining. By modulating the immune response, mesenchymal stem cells can alleviate symptoms and improve overall gut health.

Clinical trials and studies have shown promising results in patients with digestive disorders who received stem cell regenerative therapy. Patients experienced a reduction in symptoms, improved gut function, and better absorption of nutrients.

Irritable Bowel Syndrome

Recent studies using umbilical cord-derived mesenchymal stem cells (UC-MSCs) have shown promising results in the treatment of inflammatory bowel disease (IBS), including IBS with Crohn's disease and ulcerative colitis. One study focused on mouse models and found that intraperitoneal injections of UC-MSCs effectively ameliorated IBD symptoms, improved intestinal barrier function, reduced inflammation, and increased T cell proportions. Another study involving human and animal subjects treated with intravenous UC-MSC injections found significant reductions in disease activity, histopathological scores, and myeloperoxidase levels. These stem cells have demonstrated immune regulatory properties and tissue repair capabilities, leading to favorable outcomes in clinical and animal studies. Additionally, human trials using intravenous infusions of adult umbilical cord-derived mesenchymal stem cells for IBD treatment are underway. The results suggest that UC-MSCs could be a promising and novel approach for effectively treating and potentially curing inflammatory bowel disease. However, further research and studies are required to fully ascertain the extent of their effectiveness.

Celiac Disease

Celiac disease is a complex condition with multiple immunological pathways involved, making single-pathway treatments often ineffective. As a result, scientists have turned to stem cell therapy, specifically umbilical cord-derived mesenchymal stem cells (UC-MSCs), which can target multiple pathways simultaneously to treat the disease and alleviate symptoms. Since UC-MSCs possess regenerative capabilities, it helps to repair damaged tissue and reduce inflammation in the small intestine, where significant damage occurs in celiac disease. Studies have shown that MSCs can inhibit T-cell proliferation and inflammatory responses, while promoting apoptotic rates. Additionally, UC-MSCs have demonstrated potent immunomodulatory effects on gliadin-specific T cells, showing promise as a future therapeutic option for celiac disease.

Crohn's Disease

Crohn’s Disease is an Inflammatory Bowel Disease which is autoimmune in nature. Over the years, stem cell therapies have shown to be highly effective in treating autoimmune diseases in addition to digestive disorders, such as Crohn's disease. Notable studies involving umbilical cord-derived mesenchymal stem cells (UC-MSCs) have been conducted to treat this chronic condition. In one study, 82 patients with Crohn's disease received steroid maintenance therapy, with half of them randomly selected to receive UC-MSC infusions once a week for four weeks. At the 12-month follow-up, the UC-MSC group showed reduced corticosteroid dosages, as well as decreased Crohn's disease activity and symptoms compared to the control group. Similarly, a study of 46 trials in 28 animals and 18 humans found UC-MSC treatment significantly reduced the disease index and improved remission rates. These results demonstrate the regenerative and anti-inflammatory properties of UC-MSCs, making them a valuable supplementary therapy for Crohn's disease sufferers. Ongoing studies continue to explore the safety and efficacy of UC-MSCs in treating complex Perianal fistula in Perianal Crohn's disease.

While stem cell regenerative therapy for gastrointestinal issues is still under investigation, early findings suggest that it has the potential to revolutionize the treatment of these conditions. By harnessing the regenerative capabilities of stem cells, researchers aim to provide safe and effective therapies that can lead to lasting improvements in the lives of patients with gastrointestinal disorders. However, further research and trials are needed to fully understand the long-term benefits and risks of this innovative treatment approach.


"I have a diagnosis of multiple sclerosis and was involved in three rear end car accidents in the same year, resulting in a double fusion in L4 and L5. Prior to the car accidents. I had a slip and fall and a severe shoulder injury, leaving me without use of my right arm" ... I fed myself for the last three days using a spoon and a fork for the first time in over a year. "I am grateful!"

Jeannine Karklins,MS Diagnosis

Boca Raton, Florida

My Ketamine experience was by far one of the most profound healing journeys I've had so far in my life. I can honestly say I had no expectations going into my session. Dr. Ripley and his staff made me feel so welcomed, they were extremely compassionate and caring throughout the entire process. No detail was left unattended. As I entered the cozy suite, I truly felt as if I were in my own home. Dr. Ripley gave me a sense of peace of mind as he explained he will be monitoring my vitals all through the process. It was then, when I relaxed and gave into the journey. There were moments where I opened my eyes and felt so safe and comforted. The entire process lasted about an hour but I honestly felt I worked through years of unresolved trauma. As of today, I continue to benefit from having such an amazing ketamine experience with with Dr. Ripley and his team.

Jeannine Karklins,MS Diagnosis

Boca Raton, Florida

Office: Delray, Florida

Call xxx-xxx-xxxx



Copyright 2023 . All rights reserved